Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2NB22 | ISIN: DE000A2NB221 | Ticker-Symbol:
Branche
Maschinenbau
Aktienmarkt
Vor-IPO
1-Jahres-Chart  (nicht börsennotiert)
EXYTE AG Chart 1 Jahr
PR Newswire
279 Leser
Artikel bewerten:
(1)

Exyte completes acquisition of Kinetics

Finanznachrichten News
  • Closing of transaction following the approval by all required regulatory bodies
  • Acquisition of industry leader in installation services, equipment, and technical facility management
  • The company serves high-tech industries such as semiconductor, biopharma, and batteries
  • Further strengthening of Exyte's Technology & Services business

STUTTGART, Germany, Oct. 16, 2024 /PRNewswire/ -- Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the acquisition of Kinetics Group. The transaction, announced in April 2024, closed on October 15, 2024, following receipt of all required regulatory approvals.

Kinetics is a globally recognized leader in installation services, equipment, and technical facility management.

Kinetics is a globally recognized leader in installation services, equipment, and technical facility management. The company's expertise spans the biopharma, semiconductor, and high-tech industries, with operations across Asia, Europe, and North America. With the acquisition of Kinetics, Exyte significantly enhances the portfolio of its Technology & Services business area, reinforcing its position as a leader in high-tech facility solutions while also increasing its regional coverage.

"Through the acquisition of Kinetics, we are strengthening our capabilities and expanding our service offerings," says Exyte CEO Dr. Wolfgang Büchele. "Kinetics is an ideal addition to Exyte, allowing us to capitalize on the ongoing investments in high-tech facilities. Together, we will leverage new opportunities and continue providing our clients with innovative solutions."

With the transaction, Exyte also ventures into the field of technical facility management. Technical facility management services enable Exyte to extend its business activities beyond the engineering, planning, and construction phases, ensuring the continuity of its client relationships by offering services during operations.

Kinetics CEO Peter Maris adds: "Joining forces with Exyte provides Kinetics with a strategic partner committed to our sustained growth and excellence. Together, we will continue to serve our global clients with enhanced expertise and a broader range of high-tech solutions, ensuring ongoing success and innovation."

Strategic expansion of Technology & Services

Kinetics will operate within Exyte's business area Technology & Services, leveraging the combined strengths to foster innovation and growth. The business area consists of entities that provide cleanroom technology, installation services, and equipment for subsystems to their clients as well as off-site manufacturing (OSM). Exyte is currently pursuing its "Pathway to Ten" with the goal to achieve ten billion euros in sales by 2027. The business area Technology & Services is expected to contribute significantly to the company's success in the coming years.

About Exyte

Exyte is a global leader in the design, engineering, and delivery of ultra-clean and sustainable facilities for high-tech industries. With cutting-edge expertise developed over more than a century, the company serves clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers. Exyte offers a full range of services from consulting to managing the implementation of complete solutions with the highest standards in safety and quality to its customers worldwide. Exyte creates a better future by enabling key industries to enhance the quality of modern life. In 2023, the company generated sales of €7.1 billion with around 9,900 employees worldwide. www.exyte.net

More information about Kinetics can be found on www.kinetics.net.

Photo - https://mma.prnewswire.com/media/2531492/Exyte_Kinetics.jpg
Logo - https://mma.prnewswire.com/media/1487100/Exyte_Logo.jpg

Contact
Samy Abdel Aal
Public Relations Manager

Phone: +49 711 88044696
Mobil: +49 172 840 33 01
samy.abdelaal@exyte.net
www.exyte.net

Exyte is a global leader in the design, engineering, and delivery of ultra-clean and sustainable facilities for high-tech industries.

Cision View original content:https://www.prnewswire.co.uk/news-releases/exyte-completes-acquisition-of-kinetics-302277565.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.